Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Quince Therapeutics, Inc.

Quince Therapeutics, Inc.

Stage unknownSouth San Francisco, CABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. May 18, 2026
    Form D equity offering · $115M (form d sold) · 27 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Quince Therapeutics, Inc. filed Form D: $114,720,542 sold of $186,422,679, Biotechnology”
  2. Jun 18, 2025
    Form D equity offering · $11.5M (form d sold) · 15 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Quince Therapeutics, Inc. filed Form D: $11,488,304 sold of $21,896,618, Biotechnology”
Investors on record
1 edges
People
4 officers, 7 directors
Timeline
2
  1. Jun 11, 2026
    Quince Therapeutics, Inc. filed Form D: $114,720,542 sold of $186,422,679, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jul 1, 2025
    Quince Therapeutics, Inc. filed Form D: $11,488,304 sold of $21,896,618, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this company